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Purpose. To compare the photopic negative response (PhNR) of the full-ﬁeld electroretinogram (ERG) to the PhNR of the focal
ERGs in detecting glaucoma. Methods. One hundred and three eyes with glaucoma and 42 normal eyes were studied. Full-ﬁeld
ERGs were elicited by red stimuli on a blue background. The focal ERGs were elicited by a 15
◦ white stimulus spot centered on
the macula, the superotemporal or the inferotemporal areas of the macula. Results. In early glaucoma, the areas under the receiver
operating characteristic curves (AUCs) were signiﬁcantly larger for the focal PhNR (0.863–0.924) than those for the full-ﬁeld
PhNR (0.666–0.748) (P<. 05). The sensitivity was signiﬁcantly higher for the focal PhNR than for the full-ﬁeld PhNR in early
(P<. 01) and intermediate glaucoma (P<. 05). In advanced glaucoma, there was no diﬀerence in the AUCs and sensitivities
between the focal and full-ﬁeld PhNRs. Conclusions. The focal ERG has the diagnostic ability with higher sensitivity in detecting
early and intermediate glaucoma than the full-ﬁeld ERG.
1.Introduction
It has been generally believed that the activity of retinal gan-
glion cells (RGCs) contributes little to shaping the corneal
electroretinogram (ERG) elicited by ganzfeld stimuli (full-
ﬁeld ERG). However, a response has been newly identiﬁed to
originate fromRGCsthatreceivesignalsfromcones[1].This
response was termed the photopic negative response (PhNR)
[2], and it consists of a negative-going wave that follows the
photopic cone b-wave.
T h eP h N Ri ss t r o n g l ya t t e n u a t e di np r i m a t e ’ se y e s
with experimentally induced glaucoma and also in eyes
intravitreally injected with tetrodotoxin [2], a blocker of
the neural activity of retinal ganglion cells, their axons,
and amacrine cells [3, 4]. In addition to this experimental
evidence, it has been demonstrated that the PhNR was
reduced in patients with optic nerve and retinal diseases that
aﬀect mainly the RGCs and retinal nerve ﬁber layer [5–16].
We have shown that the amplitudes of the PhNR of the
full-ﬁeld cone ERG (full-ﬁeld PhNR) were correlated with
visual sensitivity, disc topography, and retinal nerve ﬁber
layer thickness in eyes with open angle glaucoma (OAG)
[16]. These results indicate that the full-ﬁeld PhNR can be
used as an objective functional measure of the RGCs in
glaucomatous eyes.
When the full-ﬁeld PhNR amplitude was used as a
diagnostic tool, the sensitivity and speciﬁcity to discrimi-
nate glaucomatous from normal eyes were 77% and 90%,
respectively[16].However,attheearlystageofglaucoma,the
sensitivity was reduced to 57%, indicating that the full-ﬁeld
PhNR is not suitable for diagnosing early glaucoma. This is
not surprising because the early glaucomatous changes begin
with localized neuronal loss in the retina and optic nerve
head that could not be detected by the full-ﬁeld ERG.
The focal ERG system originally developed by Miyake
et al. [17] is now commercially available in Japan. Recently,
we have recorded focal ERGs from patients with glaucoma
[18–20] and optic nerve diseases [21]. We found that the
PhNR of the focal ERG (focal PhNR) was also selectively
attenuatedinpatientswithOAG.Inaddition,weinvestigated2 Journal of Ophthalmology
correlation between the focal PhNR and corresponding
retinal sensitivity obtained by standard automated perimetry
(SAP). A curvilinear relationship was found between the
focal PhNR amplitude and retinal sensitivity (decibel),
in which a reduction of the focal PhNR amplitude was
associated with a small decrease of retinal sensitivity at the
early stage of glaucoma [18]. This suggests that the focal
PhNR may be used for detecting functional loss at the early
stage of glaucoma. This focal ERG system allows us to record
focal retinal responses from the paramacular regions of the
retina that are preferentially aﬀected at the early stage of
glaucoma. In our recent study, we recorded focal ERGs from
three retinal loci including the macular region, the supero-
temporal and infero-temporal areas of the macula. The
sensitivity and speciﬁcity of the focal PhNR to discriminate
early glaucoma were >90%. These ﬁndings were made with
the combined criterion in which eyes were classiﬁed as being
glaucomatous when the focal PhNR amplitudes were less
than the optimal cut-oﬀ values in either retinal locus [19].
From these results, it appeared that the focal PhNR is
betterthanthefull-ﬁeldPhNRtodiscriminateglaucomatous
from normal eyes. However, a direct comparative study
comparingthediagnosticvaluesoffull-ﬁeldandfocalPhNRs
obtained from the same eyes has not been reported although
studies using diﬀerent patient populations for the full-ﬁeld
and focal PhNRs have been done [16, 18, 19].
Thus,thepurposeofthisstudywastocomparetheability
of the full-ﬁeld and focal PhNRs to detect glaucomatous
eyes at diﬀerent stages. Importantly, the full-ﬁeld and focal
PhNRs were recorded from the same eyes.
2. Methods
2.1. Patients. One hundred and three eyes of 103 patients
with OAG were studied. Their ages ranged from 37 to
83 years with a mean ± standard deviation of 68.2 ± 9.1
years. The diagnosis of OAG was based on the presence of a
glaucomatous optic disc associated with visual ﬁeld defects
m e a s u r e db yS A P .T h ep r e s e n c eo fg l a u c o m a t o u so p t i c
disc was determined by the guideline of Japanese Society
of Glaucoma developed in 2005 (http://www.nichigan.or
.jp/member/guideline/glaucoma2.jsp). According to the
diagnostic criterion for minimal abnormality of the visual
ﬁeld [22], the visual ﬁeld defect was determined to be
glaucomatous when it met one of three criteria. (1) The
pattern deviation plot showed a cluster of three or more
nonedge points that had lower sensitivities than those in 5%
of the normal population (P<. 05), and one of the points
had a sensitivity that was lower than 1% of the population
(P<. 01), (2) the value of the corrected pattern standard
deviation was lower than that of 5% of the normal visual
ﬁeld (P<. 05), or (3) the Glaucoma Hemiﬁeld Test showed
that the ﬁeld was outside the normal limits.
Forty-two eyes of 42 age-matched normal volunteers,
ranging in age from 53 to 78 years with a mean of
67.6 ± 7.3 years, were studied. We selected normal eyes
from patients with macular hole in the fellow eye which
was treated by vitrectomy. They underwent comprehensive
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Figure 1: Ocular fundus photograph showing retinal areas which
were stimulated by focal spots with a diameter of 15 degrees.
ophthalmological examinations including measuring visual
acuity by a Snellen chart and observing the ocular fundus
by an indirect ophthalmoscope as well as a biomicroscopic
slit lamp. In addition, we performed optical coherence
tomography and SAP to rule out macular and optic nerve
diseases.
This research was conducted in accordance with the
Institutional Guidelines of Iwate Medical University, and the
procedures conformed to the tenets of the Declaration of
Helsinki. An informed consent was obtained from all sub-
jects after a full explanation of the nature of the experiments.
2.2. ERG Recordings. The pupils were maximally dilated to
approximately 8mm in diameter following topical applica-
tion of a mixture of 0.5% tropicamide and 0.5% phenyle-
phrine HCL. The recordings of the full-ﬁeld and focal ERGs
were made on the same eye on the same day. The stimulus
conditions for the recordings of the full-ﬁeld cone ERGs and
f o c a lE R G sh a v eb e e nr e p o r t e di nd e t a i l[ 16, 18].
The full-ﬁeld cone ERGs were elicited by red stimuli of
1 600cd/m2 (λmax = 644nm, half-amplitude bandwidth =
35nm) on a blue background of 40cd/m2 (λmax = 470nm,
half-amplitude bandwidth = 18nm). The duration of the
stimulus was 3msec. The stimulus and background lights
were produced by light emitting diodes (LEDs) embedded
in the contact lens.
Focal ERGs were recorded from the macular area and
from the supero-temporal and infero-temporal areas of the
macula. Responses from these areas are designated as the
center, superior/temporal, and inferior/temporal responses,
respectively (Figure 1). The stimulus system was integrated
into the infrared fundus camera (Mayo Co., Nagoya, Japan),
whichhadbeendevelopedbyMiyakeetal.[17].Thestimulus
spot was 15 degrees in diameter and was placed on the
retinal area of interest, and the position was conﬁrmed by
viewing the ocular fundus on a monitor. The intensity of
the white stimulus and background lights was 165cd/m2 and
6.9cd/m2, respectively. The stimulus duration was 10ms.
The focal ERGs were recorded with a Burian-Allen bipolarJournal of Ophthalmology 3
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Figure 2: Representative full-ﬁeld cone and focal electroretinograms recorded from a normal subject and a glaucoma patient with advanced
visual ﬁeld defects.
contact lens electrode (Hansen Ophthalmic Laboratories,
Iowa City, IA).
The responses were digitally band-pass ﬁltered from 0.5
to 1000Hz for the full-ﬁeld ERG and from 5 to 500Hz for
the focal ERG. It is often diﬃcult to determine the negative
trough of the PhNR especially in cases with reduced PhNR
amplitudes. Therefore, we measured the PhNR amplitude at
the ﬁxed time points. We determined the time of the maxi-
mumamplitudeofthePhNRinnormalsubjectsaccordingto
the method of Rangaswamy et al. [9]. We found that the full-
ﬁeld and focal PhNRs were the largest at 65ms and 70ms
after the ﬂash, respectively. Therefore, we measured PhNR
amplitudes at 65ms for the full-ﬁeld PhNR and 70ms for
the focal PhNR throughout the study (Figure 2).
2.3. Visual Field Analyses. The Humphrey Visual Field
Analyzer (Model 750, Humphrey Instruments, San Leandro,
CA, USA) was used for SAP. The SITA Standard strategy was
applied to program 24-2. From the mean deviation (MD) of
the 24-2 program, we classiﬁed patients with glaucomatous
visual ﬁelds into three groups: early (MD > −6dB;n = 41,
mean age and SD: 68.6 ± 9.8 years), intermediate (−6dB≥
MD ≥− 12dB; n = 28, 69.5 ± 8.1 years), and advanced (MD
< −12dB; n = 34, 69.4 ± 7.4 years) defects of the visual
ﬁeld. There was no signiﬁcant diﬀerence in the mean age
among the three groups. The intraocular pressures (IOPs) of
all patients were controlled under 21mmHg by eye drops,
and there was no signiﬁcant diﬀerence in the IOPs among
the groups. The averaged MDs were −3.31 ± 1.58, −8.88 ±
1.67, and −17.37 ± 4.46dB for the early, intermediate, and
advanced groups, respectively.
When the ﬁxation loss rate is higher than 20%, the ﬁeld
examination was determined to be unreliable and excluded
from the analysis. In addition, when the false-positive or
false-negative error rates exceeded 33%, the visual ﬁeld was
notusedfortheanalysis.Theintervalbetweenthevisualﬁeld
testing and ERG recording was less than 1 month.
2.4. Statistic Analyses. We used receiver operating character-
istic (ROC) curves to determine the optimal cut-oﬀ values
that yielded the highest likelihood ratio. The area under
the curve (AUC) was used to compare the ROC curves.
The comparison between AUCs was made according to the
method reported by DeLong et al. [23]. The sensitivity and
speciﬁcity of the focal PhNR were compared to that of
the PhNR of the full-ﬁeld ERGs using Fisher’s exact test.
Unpaired t tests were used to compare data between groups
with diﬀerent degrees of the visual ﬁeld defect. One-way
ANOVA was used to determine the statistical signiﬁcance
of the ERG changes in eyes with the stage of glaucoma.
These analyses were performed using commercial software
MedCalc 11.3.3 (MedCalc Software, Mariakerke, Belgium)
and Prism 5.1 (GraphPad Software Inc., San Diego, CA).
3. Results
3.1. Representative ERG Waveforms from Normal and Glauco-
matous Eyes. T h ef u l l - ﬁ e l da n df o c a lE R G sr e c o r d e df r o ma
normal control and a patient that had advanced glaucoma
with a mean deviation −13.28dB are shown in Figure 2.
Both the full-ﬁeld and focal PhNRs were reduced in the
patient compared to the normal control although there was
nochangeintheamplitudesofthea-andb-wavesinthefull-
ﬁeld and focal ERGs (Figure 2).
3.2.AveragedPhNRAmplitudesandPhNR/b-WaveAmplitude
Ratios for Diﬀerent Degrees of Visual Field Defects. We have
plotted the PhNR amplitudes and PhNR/b-wave amplitude4 Journal of Ophthalmology
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Figure 3: The PhNR amplitudes of the full-ﬁeld (a) and focal ERGs (b) center, (c) superior/temporal, and (d) inferior/temporal) are plotted
for the normal controls ( ) and glaucomatous eyes at early (), intermediate (), and advanced stages (). Bars represent means of the
PhNR amplitudes.
ratios against stages of glaucoma in Figures 3 and 4,
respectively. In both the full-ﬁeld and focal ERGs, the PhNR
amplitudes and the PhNR/b-wave amplitude ratios were
signiﬁcantly and progressively reduced with an advance in
the stage of glaucoma (P<. 0001). Even at the early
stage of glaucoma, the PhNR amplitude and PhNR/b-wave
amplitude ratio were signiﬁcantly reduced compared to that
in the normal controls for the full-ﬁeld (PhNR amplitude:
P<. 004) and focal ERGs (all retinal areas: P<. 0001).
However, for the PhNR/b-wave amplitude ratio of the full-
ﬁeld ERGs, the data of the normal control considerably
overlapped those from the early glaucoma group resulting in
no signiﬁcant diﬀerences (Figure 4(a)).
The PhNR amplitude and PhNR/b-wave amplitude ratio
of the full-ﬁeld ERGs gradually decreased as the stage of
glaucoma advanced. On the other hand, the greatest loss of
the PhNR amplitude and PhNR/b-wave amplitude ratio of
the focal ERG was seen at the early stage of glaucoma. For
example, the mean of the focal PhNR amplitude recorded
from the center was reduced from 1.24μVt o0 . 6 9μV at the
earlystageofglaucoma.Then,itslightlydecreasedto0.50μV
at the advanced stage of glaucoma despite considerable loss
of the visual sensitivity of SAP (Figure 3(b)).
The full-ﬁeld PhNR amplitude fell outside the normal
range in 29, 48, and 56% of patients of the early, inter-
mediate, and advanced groups. The focal PhNR amplitudes
of the central retinal area fell outside the normal range
in 62, 61, and 76% of patients of the early, intermediate
and advanced groups. The corresponding percentages for
the superior/temporal and inferior/temporal focal PhNR
amplitudes were 49 and 46% for the early, 59 and 57%
for the intermediate, and 85 and 79% for the advanced
groups,respectively.Thus,thefocalPhNRamplitudeshowed
abnormal values in more patients at any stages than the full-
ﬁeld PhNR amplitude. Similar results were obtained for the
PhNR/b-wave amplitude ratio.
3.3. ROC Curves of Full-Field and Focal ERGs. The cut-oﬀ
values were varied by 1.0μV steps for the full-ﬁeld PhNR
amplitude, 0.1μV for the focal PhNR amplitudes, and 0.01
for the focal PhNR/b-wave amplitude ratio for the pooled
data of glaucomatous and normal eyes. The sensitivity and
speciﬁcity were obtained for each cut-oﬀ value and plotted
to determine the ROC curves from which the AUC was
obtained (Figures 5–7, Table 1).Journal of Ophthalmology 5
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Figure 4: The PhNR/b-wave amplitude ratios of the full-ﬁeld (a) and focal ERGs (b) center, (c) superior/temporal, and (d)
inferior/temporal) are plotted for the normal controls ( ) and glaucomatous eyes at early (), intermediate (), and advanced stages ().
Bars represent means of the PhNR/b-wave amplitude ratios.
Inearlyglaucoma,thefocalPhNRamplitudecurveswere
always superior to the full-ﬁeld PhNR amplitude curves. As
a result, the AUC of the focal PhNR amplitude of the infe-
rior/temporal area was signiﬁcantly larger than that of the
full-ﬁeld PhNR amplitude (Figure 5(a), P<. 05). The AUCs
of the focal PhNR/b-wave amplitude ratio obtained from all
retinal areas were signiﬁcantly larger than those of the full-
ﬁeld PhNR/b-wave amplitude ratio (Figure 5(b), Table 1,
P = .01 for the center, P = .001 for the superior/temporal
area, and P<. 001 for the inferior/temporal area).
For eyes with intermediate glaucoma, most parts of the
ROC curves of the focal ERG amplitudes overlapped the
curve of the PhNR amplitude of the full-ﬁeld ERGs. Thus,
there was no signiﬁcant diﬀerence in the AUCs between
the focal and full-ﬁeld PhNR amplitudes (Figure 6(a)).
For the PhNR/b-wave amplitude ratio, the curves of the
focal PhNR/b-wave amplitude ratio were always higher
than those of the full-ﬁeld PhNR/b-wave amplitude ratio,
resulting in signiﬁcantly larger AUCs for the focal PhNR/b-
wave amplitude ratio than for the full-ﬁeld PhNR/b-wave
amplitude ratio (Figure 6(b), P<. 05 for the center, P<. 01
for the inferior/temporal and superior/temporal areas).
In eyes with advanced glaucoma, the ROC curves for
the PhNR amplitude and PhNR/b-wave amplitude ratio of
the focal and full-ﬁeld ERGs were overlapped (Figure 7).
The diﬀerences in the AUCs between the full-ﬁeld and focal
PhNRs for both the PhNR amplitude and PhNR/b-wave
amplitude ratio were not signiﬁcant.
3.4. Sensitivity and Speciﬁcity of Full-Field and Focal ERG
PhNR. The sensitivity and speciﬁcity were obtained with
the optimal cut-oﬀ values for the PhNR amplitude (Table 2)
and the PhNR/b-wave amplitude ratio (Table 3). Because
the likelihood ratio reveals the sensitivity/false positive
rate, the highest likelihood ratio indicates high sensitivity
and speciﬁcity. Eyes were classiﬁed as being glaucomatous
when their focal PhNR amplitudes or focal PhNR/b-wave
amplitude ratio were less than the cut-oﬀ values in either
retinal areas (combined criterion in Tables 2 and 3). In all
patient groups with diﬀerent degrees of visual ﬁeld defects,
no signiﬁcant diﬀerence was found in the speciﬁcity between
the full-ﬁeld and focal PhNRs obtained from all retinal areas
including the combined criteria.6 Journal of Ophthalmology
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Figure 5: Receiver operating characteristic (ROC) curves for the PhNR amplitude (a) and PhNR/b-wave amplitude ratio (b) of the full-ﬁeld
and focal electroretinograms. Patients with early glaucoma (n = 41, mean deviation > −6dB). PhNR: photopic negative response.
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Figure 6: Receiver operating characteristic (ROC) curves for the PhNR amplitude (a) and PhNR/b-wave amplitude ratio (b) of the full-ﬁeld
and focal electroretinograms. Patients with intermediate glaucoma (n = 28, −6dB≥ mean deviation ≥− 12dB). PhNR: photopic negative
response.Journal of Ophthalmology 7
Table 1: Area under the curve of the PhNR amplitude and PhNR/b-wave amplitude ratio.
PhNR amplitude PhNR/b-wave amplitude ratio
AUC 95% CI AUC 95% CI
Early (n = 41)
Full-ﬁeld ERG 0.748 0.638–0.839 0.666 0.551–0.768
Focal ERG
Center 0.866 0.759–0.925 0.863 0.767–0.930
Sup/temp 0.863 0.767–0.930 0.886 0.795–0.947
Inf/temp 0.874 0.780–0.938 0.924 0.841–0.971
Intermediate (n = 28)
Full-ﬁeld ERG 0.865 0.758–0.937 0.789 0.670–0.880
Focal ERG
Center 0.906 0.808–0.964 0.938 0.849–0.982
Sup/temp 0.929 0.838–0.978 0.946 0.860–0.987
Inf/temp 0.959 0.878–0.992 0.942 0.854–0.984
Advanced (n = 34)
Full-ﬁeld ERG 0.954 0.875–0.989 0.910 0.817–0.965
Focal ERG
Center 0.951 0.871–0.988 0.930 0.842–0.977
Sup/temp 0.968 0.895–0.995 0.953 0.874–0.989
Inf/temp 0.972 0.902–0.996 0.972 0.901–0.996
PhNR: photopic negative response; AUC: area under the curve; CI: conﬁdence interval; sup/temp: superior/temporal; inf/temp: inferior/temporal.
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Figure 7: Receiver operating characteristic (ROC) curves for the PhNR amplitude (a) and PhNR/b-wave amplitude ratio (b) of the full-ﬁeld
and focal electroretinograms. Patients with advanced glaucoma (n = 34, mean deviation < −12dB). PhNR: photopic negative response.8 Journal of Ophthalmology
Table 2: Sensitivity and speciﬁcity of the PhNR amplitude to discriminate glaucomatous eyes.
Sensitivity (95%CI) Speciﬁcity (95%CI) Cut-oﬀ value (μV)
Early (n = 41)
Full-ﬁeld ERG 38.1 (23.6–54.4) 92.3 (79.1–98.3) 22
Focal ERG
Center 69.1 (52.9–82.4) 95.2 (83.8–99.3) 0.7
Sup/temp 63.4 (46.9–77.9) 97.6 (87.1–99.6) 0.5
Inf/temp 56.1 (46.9–77.9) 95.2 (83.8–99.3) 0.7
Combined 88.1 (74.4–96.0) 90.5 (87.7–99.6)
Intermediate (n = 28)
Full-ﬁeld ERG 59.3 (38.8–77.6) 92.3 (79.1–98.3) 22
Focal ERG
Center 64.3 (44.1–81.3) 95.2 (83.8–99.3) 0.7
Sup/temp 75.0 (55.1–89.3) 97.6 (87.1–99.6) 0.5
Inf/temp 67.9 (47.7–84.1) 95.2 (83.8–99.3) 0.7
Combined 92.9 (87.7–99.6) 90.5 (87.7–99.6)
Advanced (n = 34)
Full-ﬁeld ERG 66.7 (48.2–82.0) 92.3 (79.1–98.3) 22
Focal ERG
Center 88.2 (72.5–96.6) 95.2 (83.8–99.3) 0.7
Sup/temp 90.9 (75.6–98.0) 97.6 (87.1–99.6) 0.5
Inf/temp 90.9 (75.6–98.0) 95.2 (83.8–99.3) 0.7
Combined 97.1 (87.7–99.6) 90.5 (87.7–99.6)
PhNR: photopic negative response; CI: conﬁdence interval; sup/temp: superior/temporal; inf/temp: inferior/temporal.
Table 3: Sensitivity and speciﬁcity of the PhNR/b-wave amplitude ratio to discriminate glaucomatous eyes.
Sensitivity (95%CI) Speciﬁcity (95%CI) Cut-oﬀ value
Early (n = 41)
Full-ﬁeld ERG 23.8 (12.1–39.5) 97.4 (86.5–99.6) 0.19
Focal ERG
Center 61.9 (45.6–76.4) 97.6 (87.4–99.6) 0.22
Sup/temp 75.6 (59.7–87.6) 97.6 (87.1–99.6) 0.23
Inf/temp 73.1 (57.1–85.3) 95.2 (83.8–99.3) 0.29
Combined 97.6 (87.7–99.6) 92.9 (87.7–99.6)
Intermediate (n = 28)
Full-ﬁeld ERG 40.7 (22.4–61.2) 97.4 (86.5–99.6) 0.20
Focal ERG
Center 67.9 (47.7–84.1) 97.6 (87.4–99.6) 0.22
Sup/temp 85.7 (67.3–95.9) 97.6 (87.1–99.6) 0.23
Inf/temp 78.6 (59.0–91.7) 95.2 (83.8–99.3) 0.29
Combined 96.4 (87.7–99.6) 92.9 (87.7–99.6)
Advanced (n = 34)
Full-ﬁeld ERG 69.7 (51.3–84.4) 97.4 (86.5–99.6) 0.20
Focal ERG
Center 70.6 (52.5–84.9) 97.6 (87.4–99.6) 0.22
Sup/temp 90.9 (75.6–98.0) 95.6 (87.1–99.6) 0.23
Inf/temp 90.9 (75.6–98.0) 95.2 (83.8–99.3) 0.29
Combined 97.1 (87.7–99.6) 92.9 (87.7–99.6)
PhNR: photopic negative response; CI: conﬁdence interval; sup/temp: superior/temporal; inf/temp: inferior/temporal.Journal of Ophthalmology 9
In patients with mild defects of the visual ﬁeld, the
sensitivities of the focal PhNR amplitudes were signiﬁcantly
higher than those of the full-ﬁeld PhNR amplitudes (P<
.01) except for the inferior/temporal area. For the PhNR/b-
wave amplitude ratio, the sensitivities of the focal ERG in
both retinal areas were signiﬁcantly higher than those of
the full-ﬁeld ERGs (P<. 001 for the center, P<. 00001
for the superior/temporal and inferior/temporal areas). The
sensitivities of the PhNR amplitude and PhNR/b-wave
amplitude ratio increased to 88.1% and 97.6%, respectively,
when the combined criterion was used, and they were
signiﬁcantlyhigherthanthecorrespondingvaluesofthefull-
ﬁeld PhNR (P<. 00001).
In intermediate and advanced glaucoma, the sensitivities
of the focal PhNRs were generally higher than those of
the full-ﬁeld PhNRs. A signiﬁcant diﬀerence was found
between the focal and full-ﬁeld PhNRs in the PhNR/b-wave
amplitude ratio obtained from the superior/temporal and
inferior/temporal areas in intermediate glaucoma (P<. 01
for the superior/temporal retinal area, P<. 05 for the
inferior/temporal area). The sensitivities of the focal PhNR
obtained by the combined criteria were signiﬁcantly higher
than those of the full-ﬁeld PhNR in intermediate glaucoma
(P<. 05 for the PhNR amplitude, P<. 005 for the PhNR/b-
wave amplitude ratio).
In advanced glaucoma, there was no signiﬁcant diﬀer-
enceinthesensitivitybetweenthefull-ﬁeldandfocalPhNRs.
4. Discussion
We compared diagnostic abilities between the full-ﬁeld and
focal PhNRs in detecting glaucomatous eyes. Our results
demonstrated that the AUCs and sensitivities were higher for
the focal PhNR than for the full-ﬁeld PhNR at the early and
intermediate stages of glaucoma. This suggests that the focal
PhNRisagoodindicatortodetectthefunctionallossinearly
and intermediate glaucoma.
4.1. Diagnostic Ability of Full-Field and Focal PhNRs. The
AUCs of the focal PhNRs were better for identifying eyes
with early and intermediate glaucoma than those of the full-
ﬁeld PhNRs. On the other hand, there was no signiﬁcant
diﬀerence in the AUCs between the focal and full-ﬁeld
PhNRs in advanced glaucoma. When the combined criterion
for the focal PhNR was used, the sensitivity increased
to 88.1% and 97.6% for the focal PhNR amplitude and
PhNR/b-wave amplitude ratio, respectively, even in early
glaucoma, while the sensitivities for the PhNR amplitude
and amplitude ratio of the full-ﬁeld ERG were 38.1% and
23.8%.TheseﬁndingsindicatethatthefocalPhNRisabetter
indicator than the full-ﬁeld PhNR in detecting functional
changes in early and intermediate glaucoma.
We selected the optimal cut-oﬀ value with the highest
likelihood ratio which maximally reduces false positive
cases. This then kept the speciﬁcity high for both PhNR
parameters. The disadvantage of the combined criterion is
that it lowers the speciﬁcity as reported although a high
sensitivity was obtained [18]. However, the speciﬁcity of the
PhNRofthefull-ﬁeldandfocalERGscouldbekeptover90%
byusingthismethodtoselecttheoptimalcut-oﬀvalues.Our
resultsindicatedthat,eveninearlyglaucoma,thefocalPhNR
had high sensitivity and speciﬁcity attained by the combined
criterion.
We have reported that a curvilinear relationship existed
between the retinal sensitivity (in decibels) measured by
perimetryandthefocalPhNRamplitude[18].Thisindicated
that 3 dB loss in the retinal sensitivity is approximately
associated with a ﬁfty percent decrease in the focal PhNR
amplitude at the early stage of glaucoma. In fact, the largest
loss of the PhNR amplitude was seen at the early stage of
glaucoma in the focal ERGs (Figures 3 and 4). On the other
hand, the full-ﬁeld PhNR amplitude gradually reduced with
advance of glaucoma. Taken together, these ﬁndings indicate
that the focal PhNR could be a better measure to detect
functional abnormalities at the early stage of glaucoma than
the full-ﬁeld PhNR.
4.2. Disadvantages of Focal PhNR. It is essential that the
o c u l a rf u n d u si sv i s i b l et ob ea b l et or e c o r dt h ef o c a l
PhNRs reliably because the stimulus areas stimulated must
bemonitoredduringtherecordingsusinganinfraredfundus
camera. It is impossible to record the focal ERG in patients
with dense opacities of the ocular media, such as cataracts
and vitreous opacities. Furthermore, opacities of the ocular
media can produce stray-light that makes the focal stimulus
larger. Therefore, we have excluded patients with clinically
signiﬁcant cataracts that aﬀected vision. On the other hand,
the stray-light eﬀect is negligible for the full-ﬁeld ERGs. In
cases with severe opacity of the ocular media, the full-ﬁeld
PhNRs would be more reliable than the focal PhNR.
Intersession variability is represented by the coeﬃcients
of variation (CV = standard deviation/mean × 100), and
it was higher for the focal PhNR than for the full-ﬁeld
PhNR [16, 18]. In addition, variations of the PhNR ampli-
tude among individuals were greater for the focal PhNR
amplitude than for the full-ﬁeld PhNR amplitude [18].
However,thisdisadvantageofthefocalPhNRcanbereduced
by using the amplitude ratio of the PhNR to the b-wave
amplitude [18]. Therefore, the PhNR/b-wave amplitude
ratio is recommended for measuring the eﬀectiveness of the
focal ERGs.
4.3. Limitations of the Present Study. The recording and
stimulus conditions of the focal ERG were diﬀerent from
those of full-ﬁeld ERG, which may explain why the focal
PhNRwasbetterthanthefull-ﬁeldPhNRindiagnosingearly
or intermediate glaucoma. First, we set the low cut ﬁlters at
0.5Hzand5Hzforthefull-ﬁeldandfocalERGs,respectively.
The higher cut-oﬀ frequency (5Hz) used to record the focal
PhNR was necessary to eliminate the drifts in the baseline.
Thus, some of the low frequency components of the PhNR
were reduced as shown in monkeys [24, 25].
Second,thefull-ﬁeldERGswereelicitedbyredstimulion
a blue background (R/B) while the focal ERGs were elicited
by white stimuli on a white background (W/W). The R/B
stimuli have been shown to be a very good combination to10 Journal of Ophthalmology
elicit large and reliable PhNRs [26]. Furthermore, the results
of our preliminary study demonstrated that the sensitivity
and speciﬁcity to discriminate glaucoma were higher for the
R/B than for the W/W stimulus conditions (Machida et al.,
IOVS 2007; 48: ARVO E-Abstract 215). Thus, the stimulus
conditions used in this study are more advantageous to
eliciting full-ﬁeld PhNRs than focal PhNRs.
Therefore, the diﬀerences in the recording and stimulus
conditions do not seem to be able to explain the current
results in which the focal PhNR was more sensitive than
the full-ﬁeld PhNR in diagnosing early and intermediate
glaucoma.
5. Conclusions
The results of this study indicate that the PhNRs of the full-
ﬁeld and focal ERGs represent functional loss of RGCs in
glaucoma at diﬀerent stages of glaucoma. The focal ERG has
the diagnostic ability with high sensitivity and speciﬁcity in
detecting glaucomatous eyes at the early and intermediate
stages, especially when the combined criterion is used. There
was no diﬀerence in the diagnostic value between the full-
ﬁeld and focal PhNRs in advanced glaucoma. Thus, the focal
PhNR can be a good functional parameter to detect early or
intermediate glaucoma.
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